Growth Metrics

Baxter International (BAX) Asset Writedowns and Impairment (2019 - 2025)

Baxter International (BAX) has disclosed Asset Writedowns and Impairment for 7 consecutive years, with $266.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 3225.0% to $266.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $290.0 million, a 44.02% decrease, with the full-year FY2025 number at $290.0 million, up 480.0% from a year prior.
  • Asset Writedowns and Impairment was $266.0 million for Q4 2025 at Baxter International, up from $2.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $325.0 million in Q3 2022 to a low of -$3.0 million in Q4 2023.
  • A 4-year average of $150.2 million and a median of $243.0 million in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 125.0% in 2023, then skyrocketed 3225.0% in 2025.
  • Baxter International's Asset Writedowns and Impairment stood at $12.0 million in 2022, then crashed by 125.0% to -$3.0 million in 2023, then skyrocketed by 366.67% to $8.0 million in 2024, then surged by 3225.0% to $266.0 million in 2025.
  • Per Business Quant, the three most recent readings for BAX's Asset Writedowns and Impairment are $266.0 million (Q4 2025), $2.0 million (Q2 2025), and $22.0 million (Q1 2025).